Welcome  |   Program  |   Bios  |   Registration  |   Hotel  |   Support and Exhibit Opportunities
Meeting Program

Continuing Medical Education (CME) is jointly sponsored by the Vanderbilt School of Medicine and the Association of American Cancer Institutes.

Sunday, October 16
11:00 am Meeting Registration Begins
12:00 pm Exhibits Open
General Session
1:00 pm

Welcome and AACI Business Meeting

President’s Report
Dr. Michael Caligiuri
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital & Solove Research Institute

Executive Director’s Report
Ms. Barbara Duffy Stewart
Association of American Cancer Institutes

Treasurer’s Report
Mr. Randall C. Main
Fred Hutchinson Cancer Research Center

Welcome
Dr. Nancy E. Davidson
University of Pittsburgh Cancer Institute
UPMC Cancer Centers

CCAF Update
Ms. Lauren E. Hackett
NYU Cancer Institute

1:45 pm

The Quest for Quality in Cost-Effective Cancer Care
With the passage of health reform, cancer centers will need to compete more aggressively to deliver better, more coordinated care at a lower cost. With extensive treatment, research and support resources, ranging from clinical protocols to advanced information technology not available in most community hospital settings, AACI centers are well positioned to provide the best patient outcomes for a wide range of cancer diagnoses. This speaker will address what metrics are important and what collaborations are necessary to assess a cancer center’s readiness to deliver high quality, coordinated care in the post health reform world.

Dr. John Peabody
Sg2

2:45 pm Break
3:00 pm

Partnerships with the Pharmaceutical Industry and the Food and Drug Administration
Successful collaborations among cancer centers, pharmaceutical companies and the FDA are necessary to expedite the development of new cancer therapies. This session explores the importance of public/private partnering for reducing disease, alleviating patient suffering, and lowering the costs associated with drug development.

Dr. Anthony Coyle
Centers for Therapeutic Innovation, Pfizer

Dr. Vicki Seyfert-Margolis
Food and Drug Administration

Dr. Frank M. Torti
Comprehensive Cancer Center of Wake Forest University

4:00 pm

CCAF Business Meeting

5:00 pm Sessions End
6:00 - 7:30 pm Welcome Reception
Monday, October 17
General Session
7:00 am Continental breakfast
7:00 am Exhibits Open
8:00 am

Partnerships in Cancer Center Networks
Many AACI centers have established formal networks or partnerships with community oncology providers that allow them to expand the reach of their cancer treatment and care expertise. This session will identify the benefits and barriers of such relationships for the cancer centers, their community partners, and the patients they serve.

Statewide Network in Partnership with Intermountain Healthcare
Dr. Mary Beckerle
Huntsman Cancer Institute
University of Utah

The Pittsburgh Model: UPCI and UPMC Cancer Centers
Dr. Nancy E. Davidson
University of Pittsburgh Cancer Institute
UPMC Cancer Centers

Statewide Cancer Care Network: Reaching the Underserved
Dr. Cheryl L. Willman
University of New Mexico Cancer Center

9:30 am

Delivery and Payment Systems for Quality Oncology Care
Dr. Allan Korn provides insight about ways to better manage the costs of providing high quality cancer care and the impact of health care reform legislation on coverage policies for cancer clinical trials. Dr. Allen Lichter will discuss ASCO’s Quality Oncology Practice Initiative (QOPI) and plans for its future development. Dr. Lawrence Shulman from Dana-Farber Cancer Institute will discuss the use of health information technology and payer contracts in a large cancer center setting.

Dr. Allan Korn
Blue Cross Blue Shield Association

Dr. Allen Lichter
ASCO

Dr. Lawrence Shulman
Dana-Farber Cancer Institute

10:30 am Break
10:45 am

Cancer Genomes and Their Implications for Research and Patients

Dr. Bert Vogelstein
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

The goal of Dr. Bert Vogelstein’s research is to develop new approaches to the prevention or treatment of cancers through a better understanding of the genes and pathways underlying their pathogenesis. Dr. Vogelstein played a seminal role in uncovering the specific genes and mutations responsible for colorectal cancer and will be recognized for his leadership in establishing a genetic model for cancer progression that has enhanced understanding of the formation and development of all cancers.

12:00 pm

AACI Awards Luncheon
2011 Distinguished Public Service Award
Rep. C.W. Bill Young (R-FL)

2011 Distinguished Public Service Award
Rep. Steve Israel (D-NY)

An Overview of the Organisation of European Cancer Institutes (OECI)
Dr. Willem van Harten

Recognition of AACI Supporters

1:30 pm New President’s Initiatives 2011-2013

Dr. William S. Dalton
Moffitt Cancer Center

2:00 pm

Partnerships with Advocates
This panel will focus on the critical role that patient advocates play in the development of cancer-related public policy, including assuring easy access to high-quality safe and effective cancer therapies. In addition, this panel will bring three advocacy groups together to discuss their important contributions to innovative, patient-centered research conducted at the nation's cancer centers.

Mr. Andy Miller
LIVESTRONG

Ms. Shelley Fuld Nasso
Susan G. Komen for the Cure®

Ms. Alison Smith
C-Change

3:00 pm

NCI Cancer Centers Branch Update
Dr. Linda K. Weiss
Office of Cancer Centers
National Cancer Institute

3:30 pm

Break

3:45 pm

Genetic Medicine of the Future: The Business of Genomics
The field of genomics has rapidly expanded to become one of the most challenging areas for cancer medicine. Understanding the genetic makeup of each patient and his/her tumor presents the possibility of allowing physicians to develop individualized treatments that might improve outcomes. Genomics, like all areas of developing science, is limited by funding and strategic business planning. This session will focus on the practical implementation issues facing cancer centers and on various approaches to bringing the science of genomics to practice.

Moderator: Dr. Michael A. Caligiuri
The Ohio State University Comprehensive Cancer Center-
James Cancer Hospital & Solove Research Institute

Dr. William L. Carroll
NYU Cancer Institute

Dr. Laura van’t Veer
Helen Diller Family Comprehensive Cancer Center, UCSF

Dr. Timothy J. Yeatman

Moffitt Cancer Center

5:00 pm Sessions End
Tuesday, October 18
7:00 am Continental Breakfast
7:30 am Exhibits Open
General Session
8:00 am

New Partnership Models
Three partnership models are explored in this session:
- International: More and more cancer centers are looking at opportunities in the international communities and these bring legal, fiscal, and intellectual property issues to the table.  Methods to strategically plan and manage global academic relationships and programs are explored.
- Telemedicine: Telemedicine programs can help cancer centers save money, improve physician relationships, and offer more efficient patient care.  Strategic technologies and alliances are explored in this session illustrating examples of how telemedicine has helped the cancer program.
- Shared facilities and resources: New collaborative models for creating and “sharing” core resources and successful shared facility arrangements will be discussed.

Dr. Oliver Bogler
University of Texas M.D. Anderson Cancer Center

Dr. Frederick J. Meyers
UC Davis School of Medicine

Dr. Dan Theodorescu
University of Colorado Cancer Center

9:15 am

The Oncology Drug Shortage: Is There a Solution?
 
Dr. Karen Hagerty
ASCO

9:45 am

Break

10:00

A Better Public Understanding of Cancer Research
In keeping with AACI’s recognition of the 40th anniversary of the National Cancer Act of 1971, Pulitzer Prize-winning author Dr. Siddhartha Mukherjee will share with AACI members his historical perspective on the past four decades of cancer research.

As described on the Pulitzer Prize website, Mukherjee’s “The Emperor of All Maladies: A Biography of Cancer”, is “an elegant inquiry, at once clinical and personal, into the long history of an insidious disease that, despite treatment breakthroughs, still bedevils medical science.”

Dr. Mukherjee will also receive the AACI Excellence in Cancer Communications Award. The award acknowledges excellence in creating a greater awareness of cancer through better understanding of its complex nature.

Dr. Siddhartha Mukherjee
Herbert Irving Comprehensive Cancer Center of Columbia University

11:00 am

Adjourn

Program Subject to Change


Continuing Medical Education

Joint Sponsorship Statement
Jointly sponsored by Vanderbilt School of Medicine and the Association of American Cancer Institutes.

Accreditation
This activity has been planned and implemented in accordance with the Essentials Areas and Policies of the Accreditation Council for CME (ACCME) through the joint sponsorship of Vanderbilt School of Medicine and the Association of American Cancer Institutes. Vanderbilt School of Medicine is accredited by the Accreditation Council for CME to provide continuing medical education for physicians.

Credit Designation
Vanderbilt School of Medicine designates this educational activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Learning Objectives
Physicians and other health care professionals who attend the meeting should be able to summarize the program content, discuss its application in clinical practice, and convey the information to administrative leaders at their centers. The program’s learning objectives are for all attendees to be able to describe and discuss:
• Necessary collaborations and metrics for assessing a cancer center’s readiness to deliver high quality, coordinated care in this era of health care reform;
• Public/private partnering for reducing disease and lowering the costs associated with drug development;
• Partnerships with payers vis-a-vis the implementation of health care reform legislation;
• New approaches to the prevention or treatment of cancers through a better understanding of the underlying genes and pathways;
• Patient education and advocacy and connecting patients to relevant information and resources;
• Approaches to bringing the science of genomics to practice and implementing it at cancer centers.

Americans with Disabilities Act
It is the policy of Vanderbilt School of Medicine not to discriminate against any person on the basis of disabilities. If you feel you need services or auxiliary aids mentioned in this act in order to fully participate in this continuing education activity, please contact Sara Arvay at 412-605-1476 or attach a note to your registration form.

Faculty Disclosure
It is the policy of Vanderbilt School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.

Target Audience
This conference is designed for basic and clinical scientists, as well as for physician-scientists from academia, industry, government, and other institutions with interest in diagnosing, preventing, and treating cancer and its long-term effects.